Objective To investigate the correlation between advanced glycation end-products (AGEs) detected by skin autofluorescence and bone metabolism in type 2 diabetes mellitus (T2DM). Methods A total of 306 T2DM patients were divided into three groups (T1, AGEs<80 AU; T2, 80 AU≤AGEs<100 AU; and T3, AGEs≥100 AU) according to the AGEs level on the skin. There were 180, 107, and 19 subjects in group T1, T2, and T3, respectively. Bone mineral density of the femur neck and lumbar vertebrae 1–4 were measured with dual-energy X-ray absorptiometry. Bone turnover biomarkers were detected with electrochemiluminescence method. Results No correlation was found between AGEs and collagen type Ⅰ β-crosslinked C-telopeptide (r=?0.006, P=0.923). AGEs were negatively correlated with osteocalcin (r=?0.14, P=0.026). After adjusting for multiple confounders, further analysis revealed that compared with the T1 group, the odds for osteoporosis increased by 58% and 14% in the T3 and T2 groups, respectively. Conclusion AGEs may negatively impact bone metabolism by inhibiting osteoblast activity in T2DM patients. |